Pemafibrate - Moligand™, ≥99% , CAS No.848259-27-8

CAS: 848259-27-8 Cat. No.: P726073 Fórmula: C28H30N2O6 Peso molecular: 490.55 PubChem CID: 11526038
Disponible para pedir
CALIDAD & PUREZA Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥99%
Synonyms
(2R)-2-[3-[[2-Benzoxazolyl[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]butanoic acid|(R)-2-[3-[[Benzoxazol-2-yl[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]butanoic acid|K 13675|K 877|K-13675|K-877|K877
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Talla
Alemania (EU)
USA*
Precio
Cantidad
1mg
P726073-1mg
—
4 Disponible
17,27€
5mg
P726073-5mg
—
3 Disponible
32,02€
25mg
P726073-25mg
—
3 Disponible
86,69€
100mg
P726073-100mg
—
3 Disponible
208,17€
500mg
P726073-500mg
—
3 Disponible
607,33€
Enter a quantity for the sizes you want to add.

Descripción general

Pemafibrate is an highly potent and selective peroxisome proliferator-activated receptor alpha (PPARα) agonist (hPPAR EC50 = 1 nM/α, 1.10 μM/γ, 1,58 μM/δ by cell-based reporter assays using respective transfectants). When administered in vivo Pemafibrate is>100-fold more effective than fenofibrate in lowering triglyceride (TG) innormal rats (1 mg/kg p.o.) and in increasing HDL-cholesterol (HDL-C) in humanapoA-I (h-apoA-I) transgenic mice (3 mg/kg p.o.). Compared to other fibrates, pemafibrate′s distinct Y-shaped structure aids in stronger PPAR-α activation, better lipid binding, greater potency, and adaptability tostructural changes caused by binding of coactivators. Pemafibrate shows anti-inflammatory activities like lowering the levels of interleukin-6, tumor necrosis factor-α, monocyte chemoattractant protein-1, vascular cell adhesion molecule-1 (VCAM-1), macrophage marker F4/80). It also exhibits antiatherogenic effects by lowering the levels of certain factors such as plasma triglycerides(TG), TG-rich lipoproteins, and apolipoprotein C-III (apoC-III), and increases lipoprotein lipase (LPL) activity and high-density lipoprotein (HDL) levels. Pemafibrate promotes fibroblast growth factor 21 and contributes to the reduction of insulin resistance.

Application:

Pemafibrate may be used in research studies tostudy its effects on lipid metabolism, inflammation, and cardiovascular health. 

Biochem/physiol Actions:

Orally active, highly potent and selective peroxisome proliferator-activated receptor alpha (PPARα) agonist with >100-fold in vivo efficacy than fenofibrate. Pemafibrate is an orally active, highly potent and selective peroxisome proliferator-activated receptor alpha (PPARα) agonist (hPPAR EC50 = 1 nM/α, 1.10 μM/γ, 1,58 μM/δ by cell-based reporter assays using respective transfectants). When administered in vivo Pemafibrate is >100-fold more effective than fenofibrate in lowering triglyceride (TG) in normal rats (1 mg/kg p.o.) and in increasing HDL-cholesterol (HDL-C) in human apoA-I (h-apoA-I) transgenic mice (3 mg/kg p.o.).

Especificaciones

Sinónimos
(2R)-2-[3-[[2-Benzoxazolyl[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]butanoic acid | (R)-2-[3-[[Benzoxazol-2-yl[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]butanoic acid | K 13675 | K 877 | K-13675 | K-877 | K877
Especificaciones y pureza
Moligand™, ≥99%
Condiciones de almacenamiento de almacenamiento
Store at -20°C
Enviado en
Ice chest + Ice pads
Este producto requiere envío en cadena de frío. Los servicios terrestres y otros servicios económicos no están disponibles.
Grado
Moligand™
Tipo de acción
AGONIST
Pureza
≥99%
Propiedades del producto
ALogP
6.2
Nombres e identificadores
Pubchem Sid
Sonrisas canónicas
CCC(C(=O)O)OC1=CC=CC(=C1)CN(CCCOC2=CC=C(C=C2)OC)C3=NC4=CC=CC=C4O3
IUPAC Name
(2R)-2-[3-[[1,3-benzoxazol-2-yl-[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]butanoic acid
InChIKey
ZHKNLJLMDFQVHJ-RUZDIDTESA-N
INCHI
1S/C28H30N2O6/c1-3-25(27(31)32)35-23-9-6-8-20(18-23)19-30(28-29-24-10-4-5-11-26(24)36-28)16-7-17-34-22-14-12-21(33-2)13-15-22/h4-6,8-15,18,25H,3,7,16-17,19H2,1-2H3,(H,31,32)/t25-/m1/s1
Isómeros SMILES
CC[C@H](C(=O)O)OC1=CC=CC(=C1)CN(CCCOC2=CC=C(C=C2)OC)C3=NC4=CC=CC=C4O3
PubChem CID
11526038
Peso molecular
490.55

Datos avanzados

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassBenzenoids
ClaseBenzene and substituted derivatives
SubclassPhenoxyacetic acid derivatives
Intermediate Tree Nodes Not available
Direct ParentPhenoxyacetic acid derivatives
Alternative Parents Benzoxazoles  Phenoxy compounds  Anisoles  Benzylamines  Methoxybenzenes  Dialkylarylamines  Alkyl aryl ethers  Oxazoles  Heteroaromatic compounds  Carboxylic acids  Monocarboxylic acids and derivatives  Azacyclic compounds  Oxacyclic compounds  Carbonyl compounds  Organic oxides  Hydrocarbon derivatives  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Phenoxyacetate - Benzoxazole - Phenoxy compound - Anisole - Benzylamine - Methoxybenzene - Dialkylarylamine - Phenol ether - Alkyl aryl ether - Azole - Heteroaromatic compound - Oxazole - Oxacycle - Carboxylic acid derivative - Carboxylic acid - Ether - Monocarboxylic acid or derivatives - Azacycle - Organoheterocyclic compound - Amine - Carbonyl group - Organic oxygen compound - Organic oxide - Organonitrogen compound - Organooxygen compound - Hydrocarbon derivative - Organic nitrogen compound - Aromatic heteropolycyclic compound
DescripciónThis compound belongs to the class of organic compounds known as phenoxyacetic acid derivatives. These are compounds containing an anisole where the methane group is linked to an acetic acid or a derivative.
External Descriptors Not available
Estructura 3D
Modelo de Estructura Química Interactiva





Objetivos asociados (humanos)
PPARA Tclin Peroxisome proliferator-activated receptor alpha (2 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PPARG Tclin Peroxisome proliferator-activated receptor gamma (15191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PPARA Tclin Peroxisome proliferator-activated receptor alpha (9197 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Objetivos asociados (no humanos)
Ppard Peroxisome proliferator-activated receptor delta (358 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mecanismos de acción
Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

5 results found

Lot NumberCertificate TypeFechaArticulo
K2510528K2510528Certificate of AnalysisSep 09, 2025 P726073
K2510531K2510531Certificate of AnalysisSep 09, 2025 P726073
K2510532K2510532Certificate of AnalysisSep 09, 2025 P726073
K2510533K2510533Certificate of AnalysisSep 09, 2025 P726073
K2510534K2510534Certificate of AnalysisSep 09, 2025 P726073
Propiedades químicas y físicas
Peso molecular490.500 g/mol
XLogP36.200
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count8
Rotatable Bond Count13
Exact Mass490.21 Da
Monoisotopic Mass490.21 Da
Topological Polar Surface Area94.300 Ų
Heavy Atom Count36
Formal Charge0
Complexity658.000
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Calculadoras de soluciones
Reseñas

Reseñas de cliente

¿Necesita ayuda para elegir la calidad?

Nuestra guía de selección de calidades cubre la pureza, el estado del estabilizador y la idoneidad de la aplicación para todas las variantes de nuestro catálogo.

Ver la guía de calidades Moligand™ →

¿Quieres que te enviemos un mensaje cuando tengamos descuentos disponibles?

Recordármelo más tarde

¡Gracias! Por favor, revisa tu bandeja de entrada de correo electrónico para confirmar.

¡Vaya! Las notificaciones están desactivadas.